The differences between batch processing and continuous manufacturing of biologics require a detailed understanding of material traceability and the effects of perturbations on material quality.

New capability captures production signals, converts them into training-ready data, and gates releases on real-world distributions so model improvements compound over time. Most teams building ...

As the industry moves toward continuous bioprocessing, more effective ways are being developed to validate viral clearance. Researchers at Asahi Kasei Bioprocess America have developed a small-scale ...

For the first time, users can enter an AI-generated world as themselves and explore it alongside others in real time, with no ...